Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Apocrine lesions of the breast].
MacGrogan G. MacGrogan G. Ann Pathol. 2025 Mar 18:S0242-6498(25)00031-8. doi: 10.1016/j.annpat.2025.03.001. Online ahead of print. Ann Pathol. 2025. PMID: 40107901 French.
Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.
Bodin S, Peuker LC, Jestin E, Alves ID, Velasco V, Ait-Arsa I, Schollhammer R, Lamare F, Vimont D, MacGrogan G, Hindié E, Beck-Sickinger AG, Morgat C. Bodin S, et al. Among authors: macgrogan g. Bioconjug Chem. 2023 Nov 15;34(11):2014-2021. doi: 10.1021/acs.bioconjchem.3c00313. Epub 2023 Aug 9. Bioconjug Chem. 2023. PMID: 37556437
Cancer cells transfer invasive properties through microRNAs contained in collagen tracks.
Rouyer L, Normand L, Richard E, Allain N, Giraud J, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Moreau K, Iggo R, MacGrogan G, Dugot-Senant N, Bouter A, Tan S, Favereaux A, Moreau V, Luco RF, Ros M, Saltel F. Rouyer L, et al. Among authors: macgrogan g. Cell Rep. 2025 Dec 23;44(12):116725. doi: 10.1016/j.celrep.2025.116725. Epub 2025 Dec 10. Cell Rep. 2025. PMID: 41379613 Free article.
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Zerdes I, Matikas A, Mezheyeuski A, Manikis G, Acs B, Johansson H, Boyaci C, Boman C, Poncet C, Ignatiadis M, Bai Y, Rimm DL, Cameron D, Bonnefoi H, Bergh J, MacGrogan G, Foukakis T. Zerdes I, et al. Among authors: macgrogan g. NPJ Breast Cancer. 2025 Mar 7;11(1):23. doi: 10.1038/s41523-025-00730-1. NPJ Breast Cancer. 2025. PMID: 40055382 Free PMC article.
Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial.
Bonnefoi H, Lerebours F, Pulido M, Arnedos M, Tredan O, Dalenc F, Guiu S, Teixeira L, Mollon D, Levy C, Verret B, Dawood H, Deiana L, Mouret Reynier MA, Augereau P, Canon JL, Huchet N, Guyonneau C, Lemonnier J, MacGrogan G, Gonçalves A, Darbo E, Iggo R. Bonnefoi H, et al. Among authors: macgrogan g. Lancet Oncol. 2025 Mar;26(3):355-366. doi: 10.1016/S1470-2045(24)00737-X. Epub 2025 Feb 17. Lancet Oncol. 2025. PMID: 39978376 Free article. Clinical Trial.
218 results